Pharmaceuticals: Generic
Korean companies specializing in generic medicines
Generic pharmaceutical manufacturers produce unpatented medications that replicate branded drugs at lower price points. Traders track this industry because aggressive pricing competition and patent expiration cliffs heavily impact profit margins. Today’s trading volume is dominated by DongKoo Bio & Pharm Co. Ltd., whereas CXI Healthcare Technology Group Limited posts the most significant one-day price growth. The table below delivers comprehensive technical and fundamental metrics for these stocks.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 011040KYUNG DONG PHARMACEUTICAL Co., Ltd | 133.05 B KRW | 4,935 KRW | 0.00% | 50.5 K | 2.25 | 7.61 | 648.16 KRW | +344.20% | 6.08% | Health technology | No rating |
 006620DongKoo Bio & Pharm Co. Ltd. | 91.13 B KRW | 3,330 KRW | −1.04% | 82.44 K | 0.87 | 2.73 | 1,220.80 KRW | +511.82% | 3.56% | Health technology | No rating |
 900120CXI Healthcare Technology Group Limited | 33.49 B KRW | 3,065 KRW | +2.34% | 1.72 K | 0.26 | 0.99 | 3,108.08 KRW | −70.74% | 0.00% | Health technology | No rating |